Microviable Therapeutics is a biotech company at pre-clinical stage, developing novel bacterial immunotherapies for oncology and AMR infectious diseases.
Microviable was incorporated in 2016, as a spinoff of the Spanish National Research Council (CSIC). Microviable has received the European Seal of Excellence two times, a growing IP portfolio and numerous national and regional awards, and the certificate of Innovative SME.
www.microviable.com
Company Details
- Employees
- 17
- Founded
- -
- Address
- Gijón, Asturias, Es
- in****@****ble.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- microviable.com
- Keywords
- Intestinal Microbiota, Intestinal disease, Clostridium difficile, Biotechnology, Microbiology, microbiota, microbiome, gut microbiota, gut health, probiotics, microbiota storage, microbiota isolation, GutAlive, anaerobes, human purified microbiota, biotherapeutics, LBPs.
- HQ
- Gijón, Asturias
Microviable Therapeutics Sl Questions
Microviable Therapeutics Sl's website is microviable.com
Microviable Therapeutics Sl's LinkedIn profile is https://es.linkedin.com/company/microviable-therapeutics-sl
Microviable Therapeutics Sl has
17 employees.
View email and phone details for 17
employees at Microviable Therapeutics Sl.
Microviable Therapeutics Sl's industry is
Pharmaceutical Manufacturing
Microviable Therapeutics Sl's top competitors are
Bioquochem (Bqc Redox Technologies),
Dogram,
Neoalgae,
Asociacion De Bioempresas Del Principado De Asturias,
Indermal,
Bosquia Nature | B Corp,
I4life I+d,
Stealth Newco,
Nanovex Biotechnologies,
Mikrobiomik.
Microviable Therapeutics Sl's support email address is info@microviable.com
Microviable Therapeutics Sl's categories are Pharmaceutical Manufacturing
Microviable Therapeutics Sl's founding year is 2016
